Concepedia

Changguo Chen

CC

Statistics

Publications

23

Citations

1.5K

H-Index

19

Active since

1997

Affiliations

University of Kentucky(Current)

Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences

PLA Navy General Hospital

Markey Cancer Center

Chinese PLA General Hospital

Changguo Chen is an author at University of Kentucky specializing in life sciences, oncology, and medicine.

ORCID

Publications per year

1997–2023

23

Publications

23

An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells

Changguo Chen, Thomas D. Johnston, Hoonbae Jeon et al. · International Journal of Pharmaceutics · 2008 · 149 citations

, , +12

PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

Roberto Gedaly, Paul Angulo, Jonathan Hundley et al. · PubMed · 2010 · 144 citations · Full text

, , +17

A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.

Abhik Bandyopadhyay, Yong Zhu, Michael L. Cibull et al. · PubMed · 1999 · 115 citations

, , +16

Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFκB activation, and IL-2 signaling

Dinesh Ranjan, Changguo Chen, Thomas D. Johnston et al. · Journal of Surgical Research · 2004 · 110 citations

, , +16

PKI-587 and Sorafenib Targeting PI3K/AKT/mTOR and Ras/Raf/MAPK Pathways Synergistically Inhibit HCC Cell Proliferation

Roberto Gedaly, Paul Angulo, Jonathan Hundley et al. · Journal of Surgical Research · 2011 · 96 citations

, , +12

1–5 of 23